Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3516)
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
43,878
Price
$2.43
Total Value
$106.62K
Shares Held After
2,833,981
% of Holdings
1.5%
Eton Pharmaceuticals, Inc. (ETON)
Opaleye Management Inc. — 10% Owner
Shares
13,315
Price
$37.54
Total Value
$499.89K
Shares Held After
40,000
% of Holdings
25.0%
Eton Pharmaceuticals, Inc. (ETON)
Opaleye Management Inc. — 10% Owner
Shares
15,000
Price
$37.54
Total Value
$563.15K
Shares Held After
2,665,000
% of Holdings
0.6%
PTC THERAPEUTICS, INC. (PTCT)
Gravier Pierre — CHIEF FINANCIAL OFFICER
Shares
3,494
Price
$80.35
Total Value
$280.74K
Shares Held After
83,986
% of Holdings
4.0%
Celcuity Inc. (CELC)
BAKER BROS. ADVISORS LP — Former 10% owner
Shares
2,838,632
Price
$102.50
Total Value
$290.96M
Shares Held After
4,372,852
% of Holdings
39.4%
Celcuity Inc. (CELC)
BAKER BROS. ADVISORS LP — Former 10% owner
Shares
261,368
Price
$102.50
Total Value
$26.79M
Shares Held After
442,940
% of Holdings
37.1%
GALECTIN THERAPEUTICS INC (GALT)
Jamil Khurram — Chief Medical Officer
Shares
16,250
Price
$5.13
Total Value
$83.28K
Shares Held After
0
% of Holdings
100.0%
ADIAL PHARMACEUTICALS, INC. (ADIL)
Coastlands Capital LP — 10% Owner
Shares
2,000
Price
$2.65
Total Value
$5.30K
Shares Held After
387,075
% of Holdings
0.5%
Cardiff Oncology, Inc. (CRDF)
Mohindru Mani — Director
Shares
34,364
Price
$1.46
Total Value
$50.00K
Shares Held After
59,067
% of Holdings
58.2%
Cardiff Oncology, Inc. (CRDF)
PACE GARY W — Director
Shares
687,285
Price
$1.46
Total Value
$1000.00K
Shares Held After
2,043,661
% of Holdings
33.6%
Fulcrum Therapeutics, Inc. (FULC)
TANG KEVIN — 10% Owner
Shares
75,952
Price
$3.58
Total Value
$271.91K
Shares Held After
6,805,952
% of Holdings
1.1%
Fulcrum Therapeutics, Inc. (FULC)
TANG KEVIN — 10% Owner
Shares
53,651
Price
$3.56
Total Value
$191.00K
Shares Held After
6,730,000
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$532.60
Total Value
$106.52K
Shares Held After
40,513
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
107
Price
$531.08
Total Value
$56.83K
Shares Held After
40,713
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
554
Price
$530.67
Total Value
$293.99K
Shares Held After
40,820
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
959
Price
$529.21
Total Value
$507.51K
Shares Held After
41,374
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
660
Price
$528.13
Total Value
$348.57K
Shares Held After
42,333
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,220
Price
$527.06
Total Value
$643.01K
Shares Held After
42,993
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,492
Price
$526.13
Total Value
$1.84M
Shares Held After
44,213
% of Holdings
7.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,468
Price
$525.16
Total Value
$770.94K
Shares Held After
47,705
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
840
Price
$524.15
Total Value
$440.28K
Shares Held After
49,173
% of Holdings
1.7%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
2,800
Price
$0.88
Total Value
$2.46K
Shares Held After
366,885
% of Holdings
0.8%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
2,729
Price
$40.57
Total Value
$110.72K
Shares Held After
539,817
% of Holdings
0.5%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
5,481
Price
$39.72
Total Value
$217.71K
Shares Held After
542,546
% of Holdings
1.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
920
Price
$73.43
Total Value
$67.56K
Shares Held After
493,936
% of Holdings
0.2%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
7,834
Price
$307.57
Total Value
$2.41M
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
40,781
Price
$306.93
Total Value
$12.52M
Shares Held After
7,834
% of Holdings
83.9%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
45,895
Price
$306.21
Total Value
$14.05M
Shares Held After
48,615
% of Holdings
48.6%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
39,090
Price
$305.02
Total Value
$11.92M
Shares Held After
94,510
% of Holdings
29.3%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
8,122
Price
$303.93
Total Value
$2.47M
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
4,139
Price
$303.07
Total Value
$1.25M
Shares Held After
8,122
% of Holdings
33.8%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
14,058
Price
$27.58
Total Value
$387.72K
Shares Held After
57,733
% of Holdings
19.6%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
10,700
Price
$27.24
Total Value
$291.44K
Shares Held After
603,621
% of Holdings
1.7%
Fulcrum Therapeutics, Inc. (FULC)
TANG KEVIN — 10% Owner
Shares
12,966
Price
$3.54
Total Value
$45.90K
Shares Held After
6,676,349
% of Holdings
0.2%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
775
Price
$73.89
Total Value
$57.26K
Shares Held After
493,016
% of Holdings
0.2%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
2,292
Price
$34.97
Total Value
$80.15K
Shares Held After
132,917
% of Holdings
1.7%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
320
Price
$307.40
Total Value
$98.37K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
7,240
Price
$306.82
Total Value
$2.22M
Shares Held After
320
% of Holdings
95.8%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
846
Price
$305.57
Total Value
$258.51K
Shares Held After
7,560
% of Holdings
10.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
8,438
Price
$304.68
Total Value
$2.57M
Shares Held After
8,406
% of Holdings
50.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
26,294
Price
$303.83
Total Value
$7.99M
Shares Held After
16,844
% of Holdings
61.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
4,584
Price
$302.79
Total Value
$1.39M
Shares Held After
43,138
% of Holdings
9.6%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
798
Price
$301.94
Total Value
$240.95K
Shares Held After
47,722
% of Holdings
1.6%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
7,301
Price
$71.52
Total Value
$522.17K
Shares Held After
217,126
% of Holdings
3.3%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
562
Price
$71.39
Total Value
$40.12K
Shares Held After
224,427
% of Holdings
0.2%
Liquidia Corp (LQDA)
Schundler Russell — General Counsel
Shares
13,692
Price
$71.52
Total Value
$979.25K
Shares Held After
605,962
% of Holdings
2.2%
Liquidia Corp (LQDA)
Schundler Russell — General Counsel
Shares
1,046
Price
$71.39
Total Value
$74.67K
Shares Held After
619,654
% of Holdings
0.2%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
18,977
Price
$71.52
Total Value
$1.36M
Shares Held After
345,805
% of Holdings
5.2%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
32,744
Price
$71.52
Total Value
$2.34M
Shares Held After
1,130,426
% of Holdings
2.8%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
1,453
Price
$71.39
Total Value
$103.73K
Shares Held After
364,782
% of Holdings
0.4%
Showing 401–450 of 3516 transactions (page 9 of 71)